FDA Approves No-Comb Treatment for Head Lice – WebMD

by lowes1 on February 8, 2012

FDA Approves No-Comb Treatment for Head Lice
WebMD
By Daniel J. DeNoon The announcement comes from Sanofi Pasteur US, which last year acquired the developer of the treatment, Topaz Pharmaceuticals. Sklice is a topical (on-the-skin) lotion containing a 0.5% solution of ivermectin, a powerful parasite …

and more »

View full post on fda – Google News

{ 0 comments }

Henry Schein Names Gerard K. Meuchner Vice President and Chief Global Communications Officer

by lowes1 on February 8, 2012

MELVILLE, N.Y., Feb. 8, 2012 /PRNewswire/ — Henry Schein, Inc. (NASDAQ: HSIC), the largest provider of health care products and services to office-based practitioners, today announced that Gerard K. Meuchner has joined the Company as Vice President and Chief Global Communications… View full post on PR Newswire: Medical Pharmaceuticals

{ 0 comments }

Nova Scotia’s drug cap affecting bottom line for pharmacies, lobby group says – Winnipeg Free Press

February 8, 2012

Nova Scotia's drug cap affecting bottom line for pharmacies, lobby group saysWinnipeg Free PressHALIFAX – A cap on generic drug prices is gradually affecting the bottom line of pharmacies across Nova Scotia, says a lobby group for pharmacists. Allison Bodnar, executive director of the Pharmacy Association of Nova Scotia, said anecdotal evidence …and more » View [...]

Read the full article →

APP Pharmaceuticals Announces Launch of Imipenem and Cilastatin for Injection … – Business Wire (press release)

February 8, 2012

APP Pharmaceuticals Announces Launch of Imipenem and Cilastatin for Injection …Business Wire (press release)SCHAUMBURG, Ill.–(BUSINESS WIRE)–APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States.and more » View full post on pharmaceutical – Google News

Read the full article →

CVS Caremark Reports Fourth Quarter and Full Year Results; 2012 Guidance Raised to Reflect Anticipated First Quarter Benefit of Prescription Transfers From Walgreens

February 8, 2012

WOONSOCKET, R.I., Feb. 8, 2012 /PRNewswire/ — CVS Caremark Corporation (NYSE: CVS) today announced revenues, operating profit and net income for the three months and year ended December 31, 2011. (Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO ) Fourth Quarter… View full post on PR Newswire: Medical Pharmaceuticals

Read the full article →

Toxic bootleg liquor made with cough medicine kills at least 22 in eastern … – Washington Post

February 8, 2012

Moneycontrol.com Toxic bootleg liquor made with cough medicine kills at least 22 in eastern …Washington PostBHUBANESWAR, India — Officials say at least 22 people have died and more are sick after drinking toxic bootleg liquor made from cough medicine in eastern India. A hospital administrator in Orissa state said the farm laborers fell ill in [...]

Read the full article →

Roche breast cancer drug gets FDA priority review – MarketWatch

February 8, 2012

Roche breast cancer drug gets FDA priority reviewMarketWatchThe FDA confirmed the action date is June 8, 2012. – "We are pleased the FDA has granted pertuzumab a Priority Review because new medicines are needed for HER2-positive breast cancer," said Hal Barron, Chief Medical Officer and Head, Global Product …FDA will speed up review of Roche [...]

Read the full article →

Sanofi Sees 2012 Profit Falling as Much as 15% on Generics – BusinessWeek

February 8, 2012

RTT News Sanofi Sees 2012 Profit Falling as Much as 15% on GenericsBusinessWeek8 (Bloomberg) — Sanofi, France's biggest drugmaker, said profit may drop as much as 15 percent this year, hurt by generic competition to its Plavix blood-thinner and Avapro hypertension drug in the US Earnings per share excluding some costs will …Sanofi warns on [...]

Read the full article →

Prismic Pharmaceuticals takes over Scarista – Pharmaceutical Business Review

February 8, 2012

Prismic Pharmaceuticals takes over ScaristaPharmaceutical Business ReviewUS-based privately held pharmaceutical company, Prismic Pharmaceuticals, has acquired the assets of Scarista Limited. Prismic has also secured Scarista's exclusive license from Amarin Neuroscience to develop, market, and out-license patents covering …and more » View full post on pharmaceutical – Google News

Read the full article →

Myasthenia Gravis Therapeutics – Pipeline Assessment and Market Forecasts to 2019

February 8, 2012

NEW YORK, Feb. 8, 2012  /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: Myasthenia Gravis Therapeutics – Pipeline Assessment and Market Forecasts to 2019… View full post on PR Newswire: Medical Pharmaceuticals

Read the full article →

← Previous Entries